Read all news items about the AGE Reader and Diagnoptics.
Groningen, the Netherlands – May 1, 2012
DiagnOptics has received approval from Health Canada for the Diab-spot. This allows the Canadian distributor of the Diab-spot, Bescot Healthcare, to also start the sale of the Diab-spot in Canada besides the already available AGE Reader.
This approval means entry to another important market for DiagnOptics: the diabetes screening market in Canada. Diab-spot offers a noninvasive and convenient method for diabetes screening with an immediate screening result on the spot.
Would you like to learn more about our products? Request any information you wish to receive here.
If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.
More information about Diagnoptics.
Information on Diagnoptics' products and Advanced Glycation Endproducts.
Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.